Akasu, M., Shimada, S., Kabashima, A., Akiyama, Y., Shimokawa, M., Akahoshi, K., . . . Tanaka, S. (2021). Intrinsic activation of β-catenin signaling by CRISPR/Cas9-mediated exon skipping contributes to immune evasion in hepatocellular carcinoma. Nature Portfolio.
Chicago Style (17th ed.) CitationAkasu, Masafumi, et al. Intrinsic Activation of β-catenin Signaling by CRISPR/Cas9-mediated Exon Skipping Contributes to Immune Evasion in Hepatocellular Carcinoma. Nature Portfolio, 2021.
MLA (8th ed.) CitationAkasu, Masafumi, et al. Intrinsic Activation of β-catenin Signaling by CRISPR/Cas9-mediated Exon Skipping Contributes to Immune Evasion in Hepatocellular Carcinoma. Nature Portfolio, 2021.
Warning: These citations may not always be 100% accurate.